Blocking C5L2 decreased C5a-primed neutrophils expression of membrane-bound PR3 (mPR3). by Jian Hao (160736)

Rhox5 decreases UNC5C expression. by Mayumi Sugimoto (151133)

Exposure to EtBr decreases mtRNA in rat striatal co-cultures, purified neuronal cultures, and astrocytes. by Emily Booth Warren (4276333)

“…Error bars reflect delta-method propagated +/-SEM, with level of significance determined following Dunn’s post-hoc test. 2D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref005" target="_blank">5</a>] = 5ng/ml EtBr for 2 days, 4D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref005" target="_blank">5</a>] = 5ng/ml EtBr for 4 days, 2D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref050" target="_blank">50</a>] = 50ng/ml EtBr for 2 days, 4D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref050" target="_blank">50</a>] = 50ng/ml EtBr for 4 days. …”

Invasion of <i>P. falciparum</i> strain 3D7 decreases as untreated RBCs are replaced with enzyme treated RBCs. by Martha A. Clark (322102)

D-4F and L-5F improves blood glucose. by Kristine C. McGrath (8269155)

D-4F and L-5F improves insulin sensitivity. by Kristine C. McGrath (8269155)

TGF-β1 treatment decreased RELN transcriptional activity, but did not affect RELN mRNA stability. by Yi Yuan (180239)

siRNA IDH1 decreased cell proliferation and migration. by Huixia Zhu (3615314)

Decrease in CD15⁺ and CD133⁺ expression in Daoy cells under hypoxia condition, upon miR-34a overexpression. by Pasqualino de Antonellis (206257)

Inhibition of PKC or Rho protein kinase decreases Ad5 wild type replication <i>in vitro</i>. by Alice Liu (4814415)

The inhibitory effects of rosiglitazone and pioglitazone on the formation of functional osteoclasts on bone slices are significantly decreased in RANKL-pretreated BMMs. by Dongfeng Zhao (258868)

Decreased <i>Pax2</i> expression in <i>p53^−/−</i> embryonic kidneys. by Zubaida Saifudeen (135684)

“…<b>B</b>) In situ hybridization. Decreased expression of <i>Pax2</i> mRNA at E12.5. …”

Inhibition of HDAC6 activity decreased the levels of EGFR and increased acetyl-α-tubulin in renal epithelial cells. by Wei Liu (20030)

“…(C) and (D) Western blotting analysis of the expression of EGFR and acetyl-α-tubulin in <i>Pkd1</i> wild-type (WT) MEK cells (C) and <i>Pkd1^null/null</i> (Null) MEK cells (D) treated with or without TSA (100 ng/ml). …”

Decreased production of highly reactive oxygen species production induced by complement-mediated phagocytosis in Rab27a-knockdown cells. by Tatsumi Kawakami (505540)

Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae by Ziyuan Zhao (2889005)

PIKfyve inhibition results in decreased melanin accumulation and decreased accumulation of advanced stage melanosomes. by Marc C. Liggins (5018390)

IFN-λ1 decreases miR-122 transcription through down regulation of HNF4α. by Fatma Aboulnasr (736868)

“…<b>(E)</b> Quantification of the bands in Fig 5D <b>(F)</b> Schematic representation of putative HNF4α binding sites in human miR-122 gene promoters and the mechanisms for how IFN-λ1 decreases miR-122 transcription through reduced binding of HNF4α to DR1 element, **p≤0.01, ***p≤0.001.…”

The TLR4 activator LPS decreases photoreceptor viability and reducesWnt-mediated protection from oxidative stress. by Hyun Yi (57741)

“…<p>(A) Muller glia-photoreceptor cultures were incubated for 24 hr in 0.4 mM H₂O₂ to induce oxidative stress, with and without recombinant Wnt3a (150 ng/ml) or the TLR4 activator LPS (5 and 50 µg/ml). …”

IL-13 levels are decreased in β-Catenin knock-down-cells compared to β-Catenin-competent cells. by Sandra Michaela Frei (481531)

PDGF-BB maintains Bcl2/Bax ratio and decreases caspase-3 activation induced by Tat and morphine. by Shaily Malik (226661)

“…<p>(A) Human neurons were treated with 100 ng/ml Tat and/or 100 nM morphine for 12 hours with or without pre-treatment with 40 ng/ml PDGF-BB. …”